GLP-1 Microdosing FAQ: Cost, Eligibility, and How It Works
What is GLP-1 microdosing?
GLP-1 microdosing refers to using GLP-1 medications at lower doses than those used in active weight loss treatment. Typically, this means doses at 30-70% of the maximum therapeutic weight loss dose. It is not an FDA-approved designation or formal protocol. The term has emerged from both patient communities and healthcare providers to describe a lower-dose, longer-term approach to ongoing metabolic support and weight maintenance.
The key distinction is that microdosing is primarily for maintenance, not for initiating weight loss. Patients using this approach have typically reached their goal weight and want to sustain it without the side effects that can occur at higher doses.
Who is microdosing for?
The Transformation Health Microdose program is designed for patients with prior GLP-1 experience who are looking to maintain weight loss long-term. You’ll want to have completed active treatment with a GLP-1 medication previously and currently have a BMI of 20 or above. This is not a starting point for someone new to GLP-1 medications.
A key qualification is that you understand how your body responds to GLP-1 treatment. Patients who have already gone through active weight loss with these medications tend to be good candidates because they know their tolerance, side effects, and what dose level works best for them.
An independent, licensed provider will evaluate your health history, prior treatment experience, and current health metrics to determine whether the Microdose program is right for you.
What dose is considered a microdose?
There is no official FDA definition for microdosing. In clinical practice and among providers, microdoses generally fall in the 30-70% range of maximum therapeutic doses.
For semaglutide, this typically translates to roughly 0.25-1.7mg weekly. For tirzepatide, microdoses are usually in the 2.5-7.5mg weekly range. The exact dose depends on your prior treatment, your current weight, and what your provider determines is appropriate for maintenance.
For specific dose reference ranges and more detailed information about how to think through dosing for your situation, see our Microdosing Chart.
Is microdosing safe long-term?
Long-term safety data for GLP-1 medications comes primarily from the SELECT trial, which followed over 17,600 patients for five years. That trial showed no new safety signals emerging over the five-year period. STEP 4 and SURMOUNT-4 trials also provide evidence that continued use at maintenance doses is both safe and effective.
That said, there is no established 10+ year safety data yet for any GLP-1 medication, whether at full dose or maintenance. This is why ongoing monitoring with your provider is important. Your provider will track your labs, side effects, and overall health regularly to make sure the medication remains appropriate for you.
Will I regain weight if I stop microdosing?
The STEP 4 trial[2] provides clear data on this. Among patients who stopped semaglutide after successful weight loss, approximately two-thirds of the lost weight returned within a year. This is not guaranteed to happen to every patient, but it represents the average outcome.
Whether you continue, reduce, or stop your medication is an individual clinical decision that you and your provider make together based on your goals, your health metrics, and how you feel on the medication. There is no single right answer here. Some patients choose to continue indefinitely. Others decide the tradeoff is not worth it. Your provider can help you think through your specific situation.
Is microdosing covered by insurance?
Transformation Health works exclusively with US-based, state-licensed compounding pharmacies. Compounded GLP-1 programs are cash-pay. No insurance is required, and we don’t bill insurance. This means predictable, transparent pricing with no surprise denials or coverage limits.
The good news is that compounded medications are eligible for FSA and HSA reimbursement if you have those accounts. You can use pre-tax dollars to pay for the program, which effectively reduces your out-of-pocket cost.
How much does microdosing cost?
The Transformation Health Microdose program is $199 per month, all-inclusive. This single monthly fee covers your medication, provider consultations, required lab work, and medical weight loss coaching. There are no additional fees, hidden charges, or surprise costs.
You can cancel anytime. If you decide the program is not right for you, you are not locked into a contract.
Does microdosing still help with appetite?
Yes, it does. Even at lower doses, GLP-1 medications continue to reduce appetite and slow gastric emptying. The appetite suppression at microdoses is less intense than at full therapeutic doses, but many patients find it sufficient for maintaining their weight loss and keeping food noise manageable.
Think of it as tuning the volume down rather than turning it off completely. Most patients on maintenance find that a lower dose still gives them the metabolic and behavioral support they need without the side effects that sometimes come with higher doses.
What is the difference between the Microdose program and the standard program?
The key differences are cost, goal, dose, and eligibility.
Cost: The Microdose program is $199/month. Standard programs (for active weight loss) range from $249-$339/month depending on which medication you choose.
Goal: Standard programs are designed for active weight loss. Microdose is for maintenance after you have reached your goal weight.
Dose: Standard programs use full therapeutic doses to drive weight loss. Microdose uses lower maintenance doses.
Eligibility: Microdose requires prior GLP-1 experience. Standard programs are for patients new to these medications.
If you are just starting out on a GLP-1 medication, you would begin with a standard program. Once you reach your goal and want to transition to maintenance, your provider can help you move to the Microdose program.
Can I switch from full dose to microdose?
Yes. Switching from full dose to a maintenance microdose is common and usually straightforward. The transition is typically gradual, meaning your provider will work with you to reduce your dose in steps over time rather than all at once.
Your provider will determine the right transition schedule based on how you are feeling, your appetite, and your weight stability. Some patients step down over a few weeks. Others may do it more gradually. Your provider’s job is to find the schedule that keeps you feeling good while reducing the medication appropriately.
Does microdosing help with things other than weight maintenance?
Emerging research is exploring GLP-1 medications for inflammation, cardiovascular health, and other metabolic conditions. However, these are not approved uses. Transformation Health focuses on medically supervised weight loss and weight maintenance.
If you are interested in exploring whether a GLP-1 medication might help with other health goals beyond weight, discuss this with your provider. They can evaluate your specific situation and advise you based on your health history and the current evidence.
What labs do I need on microdosing?
Standard lab work on the Microdose program typically includes a metabolic panel, HbA1c, and lipid panel. These are the baseline labs needed to monitor your health and make sure the medication continues to be appropriate for you.
Lab frequency on maintenance is typically every three to six months, depending on your provider’s assessment and your health profile. All lab work is included in your $199/month program fee. We use Quest or LabCorp for convenient, local lab collection.
Citations
[1] Lincoff AM, et al. “Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.” New England Journal of Medicine 2023;389(21):2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/
[2] Rubino DM, et al. “Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults.” JAMA 2021;325(14):1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/
Important: Compounded medications are not FDA-approved products. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. All prescriptions require evaluation by an independent, licensed healthcare provider. Not all patients will qualify. Results vary by individual.